Figure 2

Expression levels of plasma miRNAs (miR-34a-5p, miR-148a-3p, miR-181a-5p) in EC patients, benign esophageal diseases patients and normal controls. (A) miR-34a-5p; (B) miR-148a-3p; (C) miR-181a-5p. The expression levels of miR-34a-5p, miR-148a-3p and miR-181a-5p in EC patients, benign esophageal diseases patients and normal controls were statistically significant (P < 0.001). The level of miR-34a-5p increased, while the levels of miR-148a-3p and miR-181a-5p decreased in EC patients. All data shown as log10 copies/μL. EC: esophageal cancer. *P < 0.05, **P < 0.01, ***P < 0.001.